文献速递流行病学与生物统计

胎儿丢失与远期母亲疾病负担及死亡风险的系统综述与Meta分析

Fetal loss and long-term maternal morbidity and mortality: A systematic review and meta-analysis.
PubMed 文献 · PLoS Med · 2024-02-09

该系统综述与Meta分析检索截至2023年6月的多个数据库,纳入56项观察性研究(45项进入Meta分析),比较有死产或流产史女性与无妊娠丢失史女性的远期心血管、恶性肿瘤、精神疾病、其他疾病及全因死亡风险。结果显示,死产史与缺血性心脏病、脑血管病、任何循环/心血管疾病、2型糖尿病及肾脏疾病风险升高相关,且乳腺癌风险降低;流产史未见心血管疾病风险改变。

要点

  • 与无妊娠丢失女性相比,死产史女性缺血性心脏病风险RR 1.56(95%CI 1.30-1.88)、脑血管病风险RR 1.71(95%CI 1.44-2.03)。
  • 死产史女性任何循环/心血管疾病风险RR 1.86(95%CI 1.01-3.45),2型糖尿病风险RR 1.16(95%CI 1.07-2.26)。
  • 流产史女性缺血性心脏病风险RR 1.11(95%CI 0.98-1.27)、脑血管病风险RR 1.01(95%CI 0.85-1.21),均无显著差异。

核心结论

  • 有死产史的女性未来发生心血管疾病、2型糖尿病和肾脏疾病的风险更高;有一次或多次流产史的女性风险似乎没有改变。

研究设计与样本

  • 系统检索MEDLINE、EMBASE、AMED、BNI、CINAHL和Cochrane Library自建库至2023年6月,无语言限制。
  • 纳入56项观察性研究,其中45项进入Meta分析;包括1,119,815名有妊娠丢失的女性(951,258名流产,168,557名死产)与11,965,574名无妊娠丢失女性。
  • 采用逆方差随机效应模型,合并最调整的RR、OR和HR(罕见结局假设),报告风险比(RR)及95%置信区间(CI)和预测区间(PI)。

主要发现

  • 与无妊娠丢失女性相比,死产史女性缺血性心脏病风险RR 1.56(95%CI 1.30-1.88;p<0.001;95%PI 0.49-5.15)。
  • 死产史女性脑血管病风险RR 1.71(95%CI 1.44-2.03;p<0.001;95%PI 1.92-2.42),任何循环/心血管疾病风险RR 1.86(95%CI 1.01-3.45;p=0.05;95%PI 0.74-4.10)。
  • 流产史女性缺血性心脏病风险RR 1.11(95%CI 0.98-1.27;95%PI 0.46-2.76),脑血管病风险RR 1.01(95%CI 0.85-1.21),均无显著差异。
  • 死产史女性2型糖尿病风险RR 1.16(95%CI 1.07-2.26;p<0.001;95%PI 1.05-1.35),肾脏疾病风险RR 1.97(95%CI 1.51-2.57;p<0.001;95%PI 1.06-4.72),乳腺癌风险RR 0.80(95%CI 0.67-0.96;p=0.02;95%PI 0.72-0.93)。
  • 妊娠丢失女性长期精神疾病风险:死产史RR 1.90(95%CI 0.93-3.88;95%PI 0.34-9.51),流产史RR 1.78(95%CI 0.88-3.63;95%PI 1.13-4.16),均无显著差异。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 主要局限性包括使用汇总数据且调整程度不一,可能存在混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence suggests common pathways between pregnancy losses and subsequent long-term maternal morbidity, rendering pregnancy complications an early chronic disease marker. There is a plethora of studies exploring associations between miscarriage and stillbirth with long-term adverse maternal health; however, these data are inconclusive. METHODS AND FINDINGS: We systematically searched MEDLINE, EMBASE, AMED, BNI, CINAHL, and the Cochrane Library with relevant keywords and MeSH terms from inception to June 2023 (no language restrictions). We included studies exploring associations between stillbirth or miscarriage and incidence of cardiovascular, malignancy, mental health, other morbidities, and all-cause mortality in women without previous pregnancy loss. Studies reporting short-term morbidity (within a year of loss), case reports, letters, and animal studies were excluded. Study selection and data extraction were performed by 2 independent reviewers. Risk of bias was assessed using the Newcastle Ottawa Scale (NOS) and publication bias with funnel plots. Subgroup analysis explored the effect of recurrent losses on adverse outcomes. Statistical analysis was performed using an inverse variance random effects model and results are reported as risk ratios (RRs) with 95% confidence intervals (CIs) and prediction intervals (PIs) by combining the most adjusted RR, odds ratios (ORs) and hazard ratios (HRs) under the rare outcome assumption. We included 56 observational studies, including 45 in meta-analysis. There were 1,119,815 women who experienced pregnancy loss of whom 951,258 had a miscarriage and 168,557 stillbirth, compared with 11,965,574 women without previous loss. Women with a history of stillbirth had a greater risk of ischaemic heart disease (IHD) RR 1.56, 95% CI [1.30, 1.88]; p < 0.001, 95% PI [0.49 to 5.15]), cerebrovascular (RR 1.71, 95% CI [1.44, 2.03], p < 0.001, 95% PI [1.92, 2.42]), and any circulatory/cardiovascular disease (RR 1.86, 95% CI [1.01, 3.45], p = 0.05, 95% PI [0.74, 4.10]) compared with women without pregnancy loss. There was no evidence of increased risk of cardiovascular disease (IHD: RR 1.11, 95% CI [0.98, 1.27], 95% PI [0.46, 2.76] or cerebrovascular: RR 1.01, 95% CI [0.85, 1.21]) in women experiencing a miscarriage. Only women with a previous stillbirth were more likely to develop type 2 diabetes mellitus (T2DM) (RR: 1.16, 95% CI [1.07 to 2.26]; p < 0.001, 95% PI [1.05, 1.35]). Women with a stillbirth history had an increased risk of developing renal morbidities (RR 1.97, 95% CI [1.51, 2.57], p < 0.001, 95% [1.06, 4.72]) compared with controls. Women with a history of stillbirth had lower risk of breast cancer (RR: 0.80, 95% CI [0.67, 0.96], p-0.02, 95% PI [0.72, 0.93]). There was no evidence of altered risk of other malignancies in women experiencing pregnancy loss compared to controls. There was no evidence of long-term mental illness risk in women with previous pregnancy losses (stillbirth: RR 1.90, 95% CI [0.93, 3.88], 95% PI [0.34, 9.51], miscarriage: RR 1.78, 95% CI [0.88, 3.63], 95% PI [1.13, 4.16]). The main limitations include the potential for confounding due to use of aggregated data with variable degrees of adjustment. CONCLUSIONS: Our results suggest that women with a history of stillbirth have a greater risk of future cardiovascular disease, T2DM, and renal morbidities. Women experiencing miscarriages, single or multiple, do not seem to have an altered risk.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Vlachou F, Iakovou D, Daru J, et al. Fetal loss and long-term maternal morbidity and mortality: A systematic review and meta-analysis. PLoS Med. 2024. PMID: 38335157. doi:10.1371/journal.pmed.1004342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。